Accès ouvert · CC BY

Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma

Article scientifique 2019 Sciences de la santé Anglais

Résumé

Multiple myeloma (MM) is an incurable plasma cell neoplasm that evolves from monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Primary genomic events responsible for the development of MGUS and SMM include hyperdiploidy, translocations, and copy number alterations 1 . Secondary events causing the transformation to active MM are driven by the acquisition of somatic mutations, including single-nucleotide variants (SNVs) and insertions and deletions (indels) 1 . Large-scale genomic studies, primarily of newly diagnosed MM, have identified at least 65 significant, recurrently mutated genes affecting 5 distinct cellular pathways 1 , 2 .

Citer ce document

Coffey, D. G., Wu, Q., Towlerton, A., Ornelas, S., Morales, A. J., Xu, Y., Green, D. J., & Warren, E. H. (2019). Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma. Blood Cancer Journal. https://doi.org/10.1038/s41408-019-0238-0

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 03/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 15

Téléchargements (hors robots) : 0

Méthode de comptage